33.84
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TGTX?
Forum
Prognose
Aktiensplit
Tg Therapeutics Inc Aktie (TGTX) Neueste Nachrichten
Executive pay, auditor and board up for votes at TG Therapeutics (TGTX) 2026 meeting - Stock Titan
TG Therapeutics schedules Q1 results call, 2026 outlook for May 6 - Stock Titan
Vanguard Portfolio Management discloses 5.26% stake in TG Therapeutics (NASDAQ: TGTX) - Stock Titan
TG Therapeutics Inc (TGTX) News, Articles, Events & Latest Updates - Stocktwits
TG Therapeutics Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
TG Therapeutics (TGTX) to Report Q1 Results: Wall Street Expects Earnings Growth - Yahoo Finance
TG Therapeutics secures $750M credit facility with Blue Owl, boosts buyback to $300M - MSN
TG Therapeutics, Inc. (TGTX) Stock Analysis: Unveiling a 21.71% Upside Potential in the Biotech Space - DirectorsTalk Interviews
TGTX completes enrollment in Phase III study on subcutaneous Briumvi - MSN
TG Therapeutics (TGTX) Is Up 7.6% After Advancing Subcutaneous BRIUMVI Phase 3 Trial Enrollment Completion - Sahm
TGTX Forecast, Price Target & Analyst Ratings | TG THERAPEUTICS INC (NASDAQ:TGTX) - ChartMill
(TGTX) Volatility Zones as Tactical Triggers - Stock Traders Daily
TG Therapeutics Inc. (TGTX) posts 87.3 percent year over year revenue growth despite large Q4 2025 earnings miss. - Xã Thanh Hà
Q1 EPS Estimates for TG Therapeutics Cut by HC Wainwright - MarketBeat
New BRIUMVI studies in relapsing MS to be shown at AAN 2026 - Stock Titan
TGTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
TG Therapeutics (TGTX) Slashes 18% on Lower 2025 Sales Guidance - MSN
HC Wainwright Forecasts Lower Earnings for TG Therapeutics - MarketBeat
TG Therapeutics Inc (NASDAQ:TGTX) Shows Strong Growth and Technical Setup for Potential Upside - ChartMill
TGTX Stock Price, Quote & Chart | TG THERAPEUTICS INC (NASDAQ:TGTX) - ChartMill
TG Therapeutics Stock: Flawless Execution $500M Non-Dilutive Boost Outlook (NASDAQ:TGTX) - Seeking Alpha
A Look At TG Therapeutics (TGTX) Valuation After Recent Share Price Momentum - Yahoo Finance
Has The Market Mispriced TG Therapeutics (TGTX) After Recent Biotech Sector Coverage Swings? - Sahm
Goldman Sachs Maintains TG Therapeutics(TGTX.US) With Hold Rating, Raises Target Price to $40 - Moomoo
TGTX Completes Enrollment in Phase III Study on Subcutaneous Briumvi - The Globe and Mail
TG Therapeutics concludes enrolment in Phase III Briumvi trial - Yahoo Finance
TG Therapeutics Completes Enrollment for Phase 3 Multiple Sclerosis Trial - Moomoo
TG Therapeutics (TGTX) Stock Competitive Analysis (Marginal Gain) 2026-04-15Gap Down Stocks - Xã Thanh Hà
TG Therapeutics completes enrollment in subcutaneous BRIUMVI trial By Investing.com - Investing.com Australia
TGTX Advances with Phase 3 Trial Completion for Briumvi Treatment - GuruFocus
TG Therapeutics completes enrollment in subcutaneous BRIUMVI trial - Investing.com
MS trial completion moves TG closer to at-home BRIUMVI option - Stock Titan
Update Report: Should you avoid TG Therapeutics Inc stock right now2026 Fed Impact & Weekly Return Optimization Plans - baoquankhu1.vn
Price-Driven Insight from (TGTX) for Rule-Based Strategy - Stock Traders Daily
TG Therapeutics (TGTX) reports financial results for Q4 and full year 2025 - MSN
Fed Watch: Does TG Therapeutics Inc stock benefit from AI growth2026 Trade Ideas & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Gains Recap: Is TG Therapeutics Inc a turnaround storyQuarterly Market Summary & Safe Capital Investment Plans - baoquankhu1.vn
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo! Finance Canada
BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating, Maintains Target Price $15 - Moomoo
Fed Meeting: Can TG Therapeutics Inc expand into new marketsMarket Trend Report & Daily Momentum Trading Reports - baoquankhu1.vn
Gains Recap: Is TG Therapeutics Inc undervalued by DCF analysis - baoquankhu1.vn
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
TGTX PE Ratio & Valuation, Is TGTX Overvalued - Intellectia AI
TG Therapeutics Inc (NASDAQ:TGTX): An Affordable Growth Stock with Strong Momentum - ChartMill
TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance UK
TG THERAPEUTICS INC (1TGTX.MI) Balance Sheet - Yahoo! Finance Canada
TG Therapeutics, Inc. (TGTX) Stock Price, News, Quote & History - Yahoo! Finance Canada
TG Therapeutics Inc. (TGTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
(TGTX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
TG Therapeutics: Briumvi Performance Aiding Upside, Buybacks Limiting Downside (TGTX) - Seeking Alpha
Analyst Calls: Is TG Therapeutics Inc undervalued by DCF analysis2026 Reactions & Long-Term Safe Investment Plans - baoquankhu1.vn
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):